Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

1 Biotech Stock Set to Rebound in 2026

TheMotleyFool

0 0

1 Biotech Stock Set to Rebound in 2026: https://g.foolcdn.com/editorial/images/852588/nutrition-exercise-wellness-health.jpg

For all the enthusiasm around GLP-1s, also known as weight-loss drugs, Novo Nordisk (NYSE: NVO) tumbled nearly 42% in 2025. The once hot stock was confounded by headwinds, including rivals making progress in the weight-loss arena and the emergence of cheaper generics.

Fast-forward to 2026, and the stock is already shedding last year's bear market conditions. Shares of the maker of Wegovy are up 25% year to date. That's a new bull market and then some.

This weight-loss leader is already rebounding and could extend that bullishness this yea. Image source: Getty Images

Source Fool.com

Like: 0

NVO

Share